首页> 外国专利> Naproxen tablets with controlled drug delivery

Naproxen tablets with controlled drug delivery

机译:萘普生片,药物控制可控

摘要

Programmed release tablets, to be administered by oral route, containing from 500 to 1,200 mg of naproxen, made by mixtures of an immediate release granulate dry compacted containing from 5% to 28% of naproxen, of a controlled release granulate dry compacted containing from 72% to 95% of naproxen and of a disintegrating agent. A portion of naproxen is released in a short time, so that the drug can quickly develop its therapeutic action reaching the necessary hematic levels, while the remaining portion is released in a longer interval of time, so as to allow the therapeutic coverage till the subsequent administration. The therapeutic coverage is effective for a period of 24 hours; thus the tablets object of the present invention are suitable for a once a day administration.
机译:含有500至1,200毫克萘普生的口服控释片,是由速释颗粒干燥压片(含有5%至28%萘普生)与控释颗粒干燥压片(含有72至72毫克)的混合物制成%至95%的萘普生和崩解剂。萘普生的一部分在短时间内释放出来,因此该药物可以迅速发展其治疗作用,达到必要的血液水平,而其余部分在更长的时间间隔内释放出来,从而使治疗覆盖面达到随后的水平行政。治疗范围有效期为24小时;因此,本发明的片剂的目的适合于每天一次给药。

著录项

  • 公开/公告号DE69307807T2

    专利类型

  • 公开/公告日1997-05-15

    原文格式PDF

  • 申请/专利权人 ALFA WASSERMANN SPA IT;

    申请/专利号DE19936007807T

  • 发明设计人 MARCHI EGIDIO IT;ROTINI LEONE GABRIELE IT;

    申请日1993-09-03

  • 分类号A61K9/20;A61K31/19;

  • 国家 DE

  • 入库时间 2022-08-22 03:12:53

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号